Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04016558 · ClinicalTrials.gov registry record · NA

Behavioral Approaches to Reducing Diabetes Distress and Improving Glycemic Control

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
296
Enrollment target

NCT04016558: Completed NA study, sponsored by University of California, San Francisco.

NCT04016558 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 296 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04016558, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
296 participants
Enrollment target

Study Summary

This study is comparing three programs to reduce Diabetes Distress (the worries and concerns that people with diabetes may experience as they struggle to keep blood glucose levels in range) in adults with type 1 diabetes. About a third of participants will take part in the TunedIn program, about a third will take part in the FixIt program, and about a third in the StreamLine program.

Primary Outcome

Self-reported diabetes distress across several domains will be assessed using the Type 1 Diabetes Distress Scale (T1-DDS) a validated measure averaged across items (range 1.0-6.0 with higher scores indicating a higher level of diabetes-related distress).

Interventions

  • BEHAVIORAL StreamLine
  • BEHAVIORAL TunedIn
  • BEHAVIORAL FixIt

Trial Details

FieldValue
Enrollment Target 296 participants
Start Date 2019-09-15
Est. Completion 2023-02-15
Phase NA

What the finished NCT04016558 record still lists

NCT04016558 is an interventional study that assigns participants to a tested intervention. The registered 296 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 3 interventions - of which StreamLine is the first listed.

NCT04016558 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04016558 about?

NCT04016558 is a clinical study titled "Behavioral Approaches to Reducing Diabetes Distress and Improving Glycemic Control". This study is comparing three programs to reduce Diabetes Distress (the worries and concerns that people with diabetes may experience as they struggle to keep blood glucose levels in range) in adults with type 1 diabetes. About a third of participants will take part in the TunedIn program, about a t...

What is the current status of trial NCT04016558?

This trial is currently completed. It is a NA study. The enrollment target is 296 participants. The study started on 2019-09-15. Estimated completion is 2023-02-15.

What interventions are being tested in trial NCT04016558?

The interventions under investigation include: StreamLine (BEHAVIORAL), TunedIn (BEHAVIORAL), FixIt (BEHAVIORAL).

Who is sponsoring clinical trial NCT04016558?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04016558's enrollment target sits among peer trials

296 373rd of 2000 higher than 1,628 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05563792 · 296 participants · NA

    Options for Pain Management Using Nonpharmacological Strategies

  • NCT06828445 · 296 participants · Phase 1

    Increasing Affordable Fruits and Vegetables for Families With Food Insecurity

  • NCT06920563 · 296 participants · NA

    Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education

  • NCT06309160 · 297 participants · NA

    COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04016558, the US trial registry maintained by the National Library of Medicine. NCT04016558 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.